CD274 and non-small cell lung carcinoma: A seminal meta-analysis of advanced NSCLC randomized controlled trials of PD-(L)1 inhibitors showed that compared to chemotherapy alone, chemoimmunotherapy benefits females more than males whereas ICI monotherapy benefits males more than females27.